Health Condition 1: R05- Cough Health Condition 2: null- Surfa Yabis (Cough)
Conditions
Interventions
Intervention1: Habb e Surfa: one tablet (125mg) twice daily. Nil orally for half an hour after taking medicine
for two weeks
Control Intervention1: nil: nil
Sponsors
Central Council for Research in Unani Medicine
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients of either sex in the age group of 18-60 2. Surfa YÄ?bis (Dry Cough) of
Exclusion criteria
Exclusion criteria: 1. Upper respiratory tract Infections having productive cough. 2. Lower Respiratory Tract Infections (LRI or LRTI) including pneumonia, lung abscess, and acute bronchitis. 3.Chronic obstructive airway disease (COAD) including chronic bronchitis and emphysema. 4. Bronchiectasis, pulmonary tuberculosis, pulmonary oedema, interstitial pulmonary fibrosis 5. Tumours of larynx, bronchi, and lungs 6. High Grade Fever > 101oF 7. Drug-induced Cough (e.g., ACE Inhibitors) 8. Diabetes Mellitus, Hypertension 9. Known cases of severe hepatic, renal or cardiac ailments 10. H/o addiction (smoking, alcohol, drugs) 11. Pregnant and lactating women
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Improvement in signs and symptoms of Surfa Yabis (Cough)Timepoint: 2 WEEKS | — |
Secondary
| Measure | Time frame |
|---|---|
| Haematological and biochemical assessment for safety assessmentTimepoint: at baseline and at the end of treatment | — |
Countries
India
Contacts
Public ContactDR PRADEEP KUMAR
Central Council for Research in Unani Medicine
Outcome results
None listed